Dr. Lihua Zheng is Chief Business Officer and Co-Founder at AnHeart Therapeutics. Dr. Zheng leads business development, corporate and financing strategy for the company. He led the successful in-licensing of three clinical-stage oncology assets from Daiichi Sankyo, and also established commercial partnerships with Innovent Biologics and NewG labs with upfront and milestone payments totaling approximately $200 million plus double-digit royalties, and raised more than $100 million in private venture financing. Dr. Zheng was previously a legal and business advisor for biopharma companies at a New York-based international law firm, before he founded a boutique law firm in New York City. He received his J.D. from Fordham University School of Law and a Ph.D. in Molecular and Human Genetics from Baylor College of Medicine. He obtained his Masters and Bachelors of Science degree from Fudan University. He is licensed to practice law in the State of New York.